SOLARA ACTIVE PHARMA SCIENCES
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹45 Cr | ₹40 Cr | ₹36 Cr | ₹36 Cr | ₹36 Cr |
| Equity - Authorised | ₹120 Cr | ₹120 Cr | ₹120 Cr | ₹120 Cr | ₹120 Cr |
| Equity - Issued | ₹48 Cr | ₹48 Cr | ₹36 Cr | ₹36 Cr | ₹36 Cr |
| Equity Paid Up | ₹45 Cr | ₹40 Cr | ₹36 Cr | ₹36 Cr | ₹36 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹5.40 Cr | ₹3.29 Cr | ₹1.65 Cr | ₹1.05 Cr | ₹1.00 Cr |
| Total Reserves | ₹1,203 Cr | ₹1,051 Cr | ₹896 Cr | ₹1,463 Cr | ₹1,488 Cr |
| Securities Premium | ₹1,525 Cr | ₹1,369 Cr | ₹1,216 Cr | ₹1,216 Cr | ₹1,216 Cr |
| Capital Reserves | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Profit & Loss Account Balance | ₹-303 Cr | ₹-296 Cr | ₹-318 Cr | ₹249 Cr | ₹274 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | ₹-19 Cr | ₹-22 Cr | ₹-2.26 Cr | ₹-2.19 Cr | ₹-1.89 Cr |
| Reserve excluding Revaluation Reserve | ₹1,203 Cr | ₹1,051 Cr | ₹896 Cr | ₹1,463 Cr | ₹1,488 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹1,253 Cr | ₹1,094 Cr | ₹934 Cr | ₹1,500 Cr | ₹1,525 Cr |
| Minority Interest | ₹2.67 Cr | ₹2.67 Cr | ₹2.67 Cr | ₹2.24 Cr | ₹2.31 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹110 Cr | ₹114 Cr | ₹106 Cr | ₹235 Cr | ₹283 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹66 Cr | ₹130 Cr | ₹218 Cr | ₹315 Cr | ₹369 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹45 Cr | ₹-16 Cr | ₹-113 Cr | ₹-80 Cr | ₹-86 Cr |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | - | - | - | ₹-79 Cr | ₹-55 Cr |
| Deferred Tax Assets | ₹77 Cr | ₹75 Cr | ₹87 Cr | ₹162 Cr | ₹136 Cr |
| Deferred Tax Liability | ₹77 Cr | ₹75 Cr | ₹87 Cr | ₹83 Cr | ₹81 Cr |
| Other Long Term Liabilities | ₹19 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr | ₹34 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹53 Cr | ₹59 Cr | ₹54 Cr | ₹49 Cr | ₹37 Cr |
| Total Non-Current Liabilities | ₹183 Cr | ₹191 Cr | ₹172 Cr | ₹217 Cr | ₹299 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹274 Cr | ₹248 Cr | ₹313 Cr | ₹306 Cr | ₹276 Cr |
| Sundry Creditors | ₹274 Cr | ₹248 Cr | ₹313 Cr | ₹306 Cr | ₹276 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹105 Cr | ₹121 Cr | ₹168 Cr | ₹144 Cr | ₹174 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹2.63 Cr | ₹0.78 Cr | ₹16 Cr | ₹7.43 Cr | ₹17 Cr |
| Interest Accrued But Not Due | ₹6.31 Cr | ₹6.11 Cr | ₹3.38 Cr | ₹2.20 Cr | ₹0.92 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹96 Cr | ₹114 Cr | ₹148 Cr | ₹135 Cr | ₹156 Cr |
| Short Term Borrowings | ₹501 Cr | ₹573 Cr | ₹760 Cr | ₹649 Cr | ₹610 Cr |
| Secured ST Loans repayable on Demands | ₹501 Cr | ₹535 Cr | ₹669 Cr | ₹649 Cr | ₹610 Cr |
| Working Capital Loans- Sec | ₹501 Cr | ₹535 Cr | ₹669 Cr | ₹649 Cr | ₹610 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-501 Cr | ₹-498 Cr | ₹-578 Cr | ₹-649 Cr | ₹-610 Cr |
| Short Term Provisions | ₹14 Cr | ₹2.24 Cr | ₹1.98 Cr | ₹2.09 Cr | ₹3.77 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.33 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹14 Cr | ₹2.23 Cr | ₹1.97 Cr | ₹2.08 Cr | ₹3.44 Cr |
| Total Current Liabilities | ₹894 Cr | ₹944 Cr | ₹1,243 Cr | ₹1,101 Cr | ₹1,063 Cr |
| Total Liabilities | ₹2,333 Cr | ₹2,232 Cr | ₹2,351 Cr | ₹2,821 Cr | ₹2,890 Cr |
| ASSETS | |||||
| Gross Block | ₹2,038 Cr | ₹1,896 Cr | ₹1,876 Cr | ₹1,868 Cr | ₹1,760 Cr |
| Less: Accumulated Depreciation | ₹801 Cr | ₹705 Cr | ₹611 Cr | ₹528 Cr | ₹429 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,238 Cr | ₹1,191 Cr | ₹1,266 Cr | ₹1,340 Cr | ₹1,332 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹205 Cr | ₹280 Cr | ₹256 Cr | ₹238 Cr | ₹239 Cr |
| Non Current Investments | ₹1.62 Cr | ₹1.70 Cr | ₹1.70 Cr | ₹1.70 Cr | ₹0.42 Cr |
| Long Term Investment | ₹1.62 Cr | ₹1.70 Cr | ₹1.70 Cr | ₹1.70 Cr | ₹0.42 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹1.62 Cr | ₹1.70 Cr | ₹1.70 Cr | ₹1.70 Cr | ₹0.42 Cr |
| Long Term Loans & Advances | ₹30 Cr | ₹28 Cr | ₹24 Cr | ₹29 Cr | ₹55 Cr |
| Other Non Current Assets | ₹0.30 Cr | ₹0.43 Cr | ₹0.48 Cr | ₹0.51 Cr | ₹0.48 Cr |
| Total Non-Current Assets | ₹1,474 Cr | ₹1,503 Cr | ₹1,550 Cr | ₹1,633 Cr | ₹1,651 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹3.00 Cr | - | - | - | - |
| Quoted | ₹3.00 Cr | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹318 Cr | ₹318 Cr | ₹360 Cr | ₹558 Cr | ₹576 Cr |
| Raw Materials | ₹86 Cr | ₹79 Cr | ₹82 Cr | ₹119 Cr | ₹131 Cr |
| Work-in Progress | ₹151 Cr | ₹160 Cr | ₹143 Cr | ₹275 Cr | ₹250 Cr |
| Finished Goods | ₹71 Cr | ₹71 Cr | ₹126 Cr | ₹156 Cr | ₹188 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹9.79 Cr | ₹8.24 Cr | ₹8.27 Cr | ₹8.12 Cr | ₹6.63 Cr |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹439 Cr | ₹327 Cr | ₹349 Cr | ₹537 Cr | ₹490 Cr |
| Debtors more than Six months | ₹17 Cr | ₹46 Cr | ₹63 Cr | ₹91 Cr | ₹34 Cr |
| Debtors Others | ₹432 Cr | ₹307 Cr | ₹312 Cr | ₹462 Cr | ₹466 Cr |
| Cash and Bank | ₹50 Cr | ₹4.11 Cr | ₹8.60 Cr | ₹8.89 Cr | ₹47 Cr |
| Cash in hand | ₹0.01 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.10 Cr | ₹0.04 Cr |
| Balances at Bank | ₹50 Cr | ₹4.09 Cr | ₹8.58 Cr | ₹8.79 Cr | ₹47 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹20 Cr | ₹29 Cr | ₹19 Cr | ₹23 Cr | ₹18 Cr |
| Interest accrued on Investments | ₹0.36 Cr | ₹0.02 Cr | ₹0.01 Cr | - | ₹1.38 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | ₹0.98 Cr | ₹1.17 Cr |
| Prepaid Expenses | ₹13 Cr | ₹16 Cr | ₹11 Cr | ₹9.99 Cr | ₹8.41 Cr |
| Other current_assets | ₹6.18 Cr | ₹12 Cr | ₹7.41 Cr | ₹12 Cr | ₹6.98 Cr |
| Short Term Loans and Advances | ₹29 Cr | ₹52 Cr | ₹52 Cr | ₹60 Cr | ₹109 Cr |
| Advances recoverable in cash or in kind | ₹12 Cr | ₹9.85 Cr | ₹11 Cr | ₹3.52 Cr | ₹4.97 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹16 Cr | ₹42 Cr | ₹41 Cr | ₹57 Cr | ₹104 Cr |
| Total Current Assets | ₹858 Cr | ₹729 Cr | ₹788 Cr | ₹1,188 Cr | ₹1,239 Cr |
| Net Current Assets (Including Current Investments) | ₹-36 Cr | ₹-215 Cr | ₹-455 Cr | ₹86 Cr | ₹176 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹2,333 Cr | ₹2,232 Cr | ₹2,351 Cr | ₹2,821 Cr | ₹2,890 Cr |
| Contingent Liabilities | ₹564 Cr | ₹60 Cr | ₹60 Cr | ₹3.61 Cr | ₹3.22 Cr |
| Total Debt | ₹665 Cr | ₹776 Cr | ₹999 Cr | ₹1,001 Cr | ₹1,025 Cr |
| Book Value | - | 271.04 | 258.96 | 416.43 | 423.30 |
| Adjusted Book Value | 280.27 | 271.04 | 238.67 | 383.80 | 390.13 |
Compare Balance Sheet of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹3,301.3 Cr | -5.7% | 6.8% | 12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | -5.7% |
6.8% |
12.9% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses